133 related articles for article (PubMed ID: 753456)
1. The role of bone scanning in the assessment of prostatic carcinoma.
McGregor B; Tulloch AG; Quinlan MF; Lovegrove F
Br J Urol; 1978 May; 50(3):178-81. PubMed ID: 753456
[TBL] [Abstract][Full Text] [Related]
2. Bone scanning and plasma phosphatases in carcinoma of the prostate.
O'Donoghue EP; Constable AR; Sherwood T; Stevenson JJ; Chisholm GD
Br J Urol; 1978 May; 50(3):172-7. PubMed ID: 753455
[TBL] [Abstract][Full Text] [Related]
3. Bone scintigraphy and serum phosphatases in the detection and follow-up of bone metastases in prostatic cancer.
Liewendahl K; Alfthan O; Ikonen T; Ruutu M; Rannikko S
Scand J Urol Nephrol; 1984; 18(3):181-5. PubMed ID: 6494827
[TBL] [Abstract][Full Text] [Related]
4. Serial bone scanning: the assessment of treatment response in carcinoma of the prostate.
Fitzpatrick JM; Constable AR; Sherwood T; Stephenson JJ; Chisholm GD; O'Donoghue EP
Br J Urol; 1978 Dec; 50(7):555-61. PubMed ID: 753508
[TBL] [Abstract][Full Text] [Related]
5. [The diagnostic value of radiological, nuclear medicine and biochemical methods for detection of bone metastases in carcinoma of the prostate (author's transl)].
Rost A; Fiedler U; Marshall F; Koppenhagen K
Radiologe; 1977 Jun; 17(6):249-55. PubMed ID: 887744
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of raised prostatic acid phosphatase and negative skeletal scintigraphy in prostatic cancer.
Goodman CM; Cumming JA; Ritchie AW; Chisholm GD
Br J Urol; 1991 Jun; 67(6):622-5. PubMed ID: 2070208
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of alkaline and acid phosphatase and skeletal scintigraphy in carcinoma of the prostate.
Merrick MV; Ding CL; Chisholm GD; Elton RA
Br J Urol; 1985 Dec; 57(6):715-20. PubMed ID: 4084732
[TBL] [Abstract][Full Text] [Related]
8. [Phosphatases and bone scan in prostatic cancer].
Urrutia M; Montero J; Grade J; Llopis M
Actas Urol Esp; 1977; 1(4):207-12. PubMed ID: 567001
[No Abstract] [Full Text] [Related]
9. Bone scan: in clinical perspective.
Bisson J; Vickers M; Fagan WT
J Urol; 1974 May; 111(5):665-9. PubMed ID: 4823975
[No Abstract] [Full Text] [Related]
10. Serial bone scanning in the evaluation of stage and clinical course in carcinoma of the prostate.
Johansson JE; Beckman KW; Lindell D; Lingårdh ; Rydman H; Vikterlöf KJ
Scand J Urol Nephrol Suppl; 1980; 55():31-6. PubMed ID: 6938033
[TBL] [Abstract][Full Text] [Related]
11. Comparison of enzyme, clinical, radiographic, and radionuclide methods of detecting bone metastases from carcinoma of the prostate.
Schaffer DL; Pendergrass HP
Radiology; 1976 Nov; 121(2):431-4. PubMed ID: 981622
[TBL] [Abstract][Full Text] [Related]
12. Total bone uptake in management of metastatic carcinoma of the prostate.
Dann J; Castronovo FP; McKusick KA; Griffin PP; Strauss HW; Prout GR
J Urol; 1987 Mar; 137(3):444-8. PubMed ID: 3102758
[TBL] [Abstract][Full Text] [Related]
13. Assessment of value of routine bone scans in patients with newly diagnosed prostate cancer.
Gerber G; Chodak GW
Urology; 1991 May; 37(5):418-22. PubMed ID: 2024388
[TBL] [Abstract][Full Text] [Related]
14. [Correlation and development of the enzyme activity of phosphatases and the gammagraphic distribution of bone deposits in prostatic cancer (preliminary study)].
Maganto Pavón E; Mateos Torres JA; Verdú Tartajo F; Boronat Tormo F; Mayayo Dehesa T; Romero Aguirre C
Actas Urol Esp; 1981; 5(2):93-8. PubMed ID: 7270286
[No Abstract] [Full Text] [Related]
15. Bone imaging and serum phosphatases in prostatic carcinoma.
Bishop MC; Hardy JG; Taylor MC; Wastie ML; Lemberger RJ
Br J Urol; 1985 Jun; 57(3):317-24. PubMed ID: 4005501
[TBL] [Abstract][Full Text] [Related]
16. [Measurement of skeletal alkaline phosphatase in prostatic carcinoma. Preliminary report].
Casetta G; Gamba P; Piana P; Pecchio F; Tizzani A
Minerva Urol Nefrol; 1995 Mar; 47(1):9-12. PubMed ID: 7570264
[TBL] [Abstract][Full Text] [Related]
17. New diagnostic use of bone marrow acid and alkaline phosphatase.
Yarrison G; Mertens BF; Mathies JC
Am J Clin Pathol; 1976 Oct; 66(4):667-71. PubMed ID: 970368
[TBL] [Abstract][Full Text] [Related]
18. Bone scintigraphy, radiographic survey and prostatic acid phosphatase in patients with prostatic carcinoma. A comparison of sensitivity.
Reikerås O; Due J; Sundsfjord JA
Int Urol Nephrol; 1988; 20(1):51-4. PubMed ID: 3283071
[TBL] [Abstract][Full Text] [Related]
19. Incidence and sites of bone lesions detected by 99mTc-polyphosphate scans in patients with tumors.
Belliveau RE; Spencer RP
Cancer; 1975 Aug; 36(2):359-63. PubMed ID: 1157007
[TBL] [Abstract][Full Text] [Related]
20. Radioimaging of the prostate and metastases of prostatic carcinoma with 99mTc-labelled prostatic acid phosphatase-specific antibodies and their Fab fragments.
Vihko P; Heikkilä J; Kontturi M; Wahlberg L; Vihko R
Ann Clin Res; 1984; 16(1):51-2. PubMed ID: 6742767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
